Related Experiment Video
Updated: Feb 14, 2026
03:17
Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
1.1K
Managing Dyslipidemia in Type 2 Diabetes.
Adam J Nelson1, Simon K Rochelau1, Stephen J Nicholls1
1South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA 5001, Australia.
Endocrinology and Metabolism Clinics of North America
|February 7, 2018
Summary
Individuals with diabetes face a higher risk of cardiovascular disease and atherosclerotic events. Effective management of diabetic dyslipidemia is crucial for mitigating these risks.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Disorders
Background:
- Cardiovascular disease (CVD) is a leading cause of death in diabetic patients.
- Diabetics have a twofold higher risk of atherosclerotic events despite risk reduction efforts.
- Insulin resistance in diabetes alters lipid profiles, complicating treatment.
Purpose of the Study:
- To review the background of diabetic dyslipidemia.
- To summarize current management strategies for diabetic dyslipidemia.
Main Methods:
- Literature review of studies on diabetes, dyslipidemia, and cardiovascular disease.
- Analysis of lipid profile changes associated with diabetes and insulin resistance.
- Overview of established and emerging treatment options.
Main Results:
- Diabetic dyslipidemia is characterized by specific lipid profile abnormalities.
- Aggressive management of traditional risk factors is essential.
- Current treatments aim to normalize lipid levels and reduce cardiovascular risk.
Conclusions:
- Diabetic dyslipidemia significantly increases cardiovascular morbidity and mortality.
- Comprehensive management of lipid disorders is a cornerstone of cardiovascular risk reduction in diabetes.
- Further research into optimal therapeutic approaches is warranted.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
01:20Pathophysiology of Diabetes
3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
01:19Psychoneuroimmunology: Diabetes and Cancer
511
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
511
01:13meta-Directing Deactivators: –NO2, –CN, –CHO, –CO2R, –COR, –CO2H
6.8K
All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.8K